Featured Alzheimer's Disease Clinical Trials
Purpose: To test whether an anti-amyloid investigational drug, solanezumab, can slow memory and cognitive decline in older individuals who do not yet show symptoms of Alzheimer's disease cognitive impairment or dementia.
Purpose: To determine the safety and efficacy of the experimental drug AZD0530 in older adults with mild Alzheimer's disease.
Purpose: To identify people interested in participating in research studies or clinical trials based in part on their genetic background.
Purpose: To learn about thinking and behavior in families in which one or more relatives has a genetic mutation associated with frontotemporal dementia.
Purpose: To evaluate a new radioactive compound used in positron emission tomography scans to identify tau tangles.